Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 2 of the 11 sources its claims cite were checked for support.
Abstract
Resistance in bovine Pasteurella multocida and Mannheimia haemolytica was absent or low, except for tetracycline.
Overview
CoChat Summary
## TL;DR
This pan-European VetPath survey found that most bovine and porcine respiratory pathogens had low antimicrobial resistance in 2019–2020, with tetracycline as the main exception. Resistance patterns were broadly similar to 2009–2012 and 2015–2016, but country-to-country differences were significant for some antibiotics, especially tetracycline.
## Key findings
- In the 2019–2020 collection, the study analyzed 307 cattle isolates and 659 pig isolates; the full collection totaled 966 clinical isolates.
- Across all 929 isolates in the MDR analysis, 17 (1.8%) were multidrug-resistant; MDR was 6.2% in bovine *P. multocida* (9 isolates), 2.3% in *M. haemolytica* (3 isolates), 0.7% in porcine *A. pleuropneumoniae* (1 isolate), and 1.7% in *S. suis* (4 isolates).
- In cattle, resistance was generally low, except tetracycline: 29.7% in *P. multocida* and 19.6% in *M. haemolytica*; *H. somni* was described as fully susceptible to all tested antibiotics.
- In pigs, resistance to ceftiofur, enrofloxacin, florfenicol, and penicillin in *P. multocida*, *A. pleuropneumoniae*, and *S. suis* was absent or <3.0%, but tetracycline resistance reached 11.4% in *P. multocida*, 13.9% in *A. pleuropneumoniae*, and 83.2% in *S. suis*.
## Methods
- The study used a pan-European surveillance design within VetPath, retrospectively comparing resistance in 2019–2020 with 2009–2012 and 2015–2016.
- Samples were non-replicate nasopharyngeal/nasal or lung swabs from animals with acute respiratory signs; cattle pathogens included *P. multocida*, *M. haemolytica*, and *H. somni*, and pig pathogens included *P. multocida*, *A. pleuropneumoniae*, *G. parasuis*, *B. bronchiseptica*, and *S. suis* (with *S. suis* also from meningitis cases).
- Susceptibility testing used broth microdilution MICs against 24 antibiotics/antibiotic combinations, interpreted with CLSI veterinary breakpoints where available; time trends were tested with Mann–Whitney, and country comparisons with χ2 tests and pairwise comparisons.
## Limitations
- The paper states that some isolates came from animals with unknown clinical history and that this could bias results; it also notes that if cases were enriched for treatment failure or recurrence, resistance might appear higher than in the general population, meaning the study may be a worst-case situation and real field resistance could be lower.
- The paper states that breed, type, and size of holding were not always available.
- Evident from the text: resistance could not be classified for all antibiotics/species because CLSI breakpoints were missing for some compounds and species, limiting comparability and possibly underestimating MDR.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
2 Valid · 0 Not valid · 9 Not checked · 141 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The obtained MIC50 values in this current study were slightly lower for several antibiotics than those in a study on 2,046 G. parasuis isolates recovered in Germany from 2006 to 2021 (Wiencek et al., 2022).”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Discussion
What the sources say
- Supportedcites Wiencek et al., 2022 source
Results §2.1 reports 2,046 G. parasuis-positive pigs evaluated for 2006–2021, and Methods §4.1 places the sampling in Germany. Results §2.2 identifies the study’s MIC distributions, while Methods §4.4 says MIC50 values were calculated. The ‘slightly lower’ comparison is the citing authors’ comparison with their own results, not a finding attributed to Wiencek et al.; the citation correctly identifies the reference study. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The above results together with our findings (0.0 to 3.0% resistance to five compounds) are compatible with the older results of S. suis isolates from seven EU countries (Wisselink et al., 2006).”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Discussion
What the sources say
- Supportedcites Wisselink et al., 2006 source
The Abstract identifies a study of 384 S. suis isolates from diseased pigs in seven European countries and reports that all isolates were susceptible to four tested agents. The 0.0–3.0% figure describes the citing authors’ own findings, not a result attributed to Wisselink et al. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Cattle isolates In cattle, a total of 307 isolates were recovered from BRD cases: 145 P. multocida, 133 M. haemolytica and 29 H. somni (Supplementary Tables S4–S6). The large majority of these were susceptible to antibiotics for which a CLSI veterinary breakpoint is available. Resistance to ceftiofur was absent in all three organisms. For amoxicillin and cefquinome, no CLSI breakpoints are available. Amoxicillin shows a bimodal MIC distribution for M. haemolytica, suggesting the development of resistance in some isolates, whereas one P. multocida isolate had a distinctly higher MIC value. In contrast, MIC distribution for amoxicillin/clavulanic acid was monomodal, as applies to cefquinome and ceftiofur. The bovine isolates ranged in their colistin MICs between ≤0.06 and 16 μg mL−1 with MIC50 and MIC90 values of 0.25 and 0.25–2 μg mL−1, respectively. The MIC distributions for marbofloxacin were similar to that of enrofloxacin and danofloxacin, for which clinical resistance was low (0.8–2.8%). Similarly, resistance to florfenicol was low (2.1–2.3%) for the isolates from both species. The highest resistance percentage was observed for tetracycline at 29.7% for P. multocida and 19.6% for M. haemolytica, whereas resistance of H. somni was 3.5%. All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%. MIC values for the older macrolide tilmicosin were similar, whereas MICs for tylosin were markedly higher for P. multocida and M. haemolytica. For both species, MIC90 values were 16–128 μg mL−1 for tiamulin and lincomycin, while both compounds showed markedly lower MIC90 values for H. somni (0.5 and ≤4 μg mL−1, respectively). Lincomycin/spectinomycin and trimethoprim/sulfamethoxazole exhibited broad multimodal MIC patterns. While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Resistance to tiamulin amounted to 2.0% in A. pleuropneumoniae; the only species where a breakpoint for tiamulin has been set.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Pig isolates In total 659 isolates were recovered from SRD cases: 149 P. multocida, 151 A. pleuropneumoniae, 37 G. parasuis, 90 B. bronchiseptica from respiratory infections and 232 S. suis from respiratory tract infections (79 isolates) or meningitis infections (153 isolates) (Supplementary Tables S7–S11). With respect to the three primary species P. multocida, A. pleuropneumoniae and S. suis, resistance to the antibiotics tested was zero to low (0.0–5.3%), except for tetracycline where 11.4% of P. multocida, 13.9% of A. pleuropneumoniae and 83.2% of S. suis were resistant, and tilmicosin (11.3% resistant for A. pleuropneumoniae). Similarly, the percentage of isolates classified as intermediate was 0.0–7.3% for P. multocida, A. pleuropneumoniae and S. suis, except for tetracycline (13.4, 2.0 and 12.1% resistance, respectively). Few Pasteurella, Actinobacillus and S. suis isolates were out of the wild-type distribution for amoxicillin. Remarkably, for these three species the amoxicillin/clavulanic acid MICs showed a narrower range than for amoxicillin. MIC distributions of cefquinome and ceftiofur were similar, and resistance to ceftiofur was only observed for four S. suis isolates (1.7% resistance) (no CLSI breakpoints available for cefquinome). The colistin MIC distributions were primarily monomodal for P. multocida and A. pleuropneumoniae; for S. suis very high colistin MIC values exceeding 32 μg mL−1 were observed, which is in accordance with the intrinsic resistance of S. suis to colistin. MIC values for the three fluoroquinolones were similarly distributed. Almost all (>96.0%) P. multocida, and A. pleuropneumoniae isolates were susceptible to tulathromycin and tildipirosin. Low levels of tilmicosin resistance were observed for P. multocida (0.7%) and a moderate level for A. pleuropneumoniae (11.3%). For S. suis, the MIC distributions for tilmicosin, tylosin, and lincomycin were clearly bimodal, indicating acquired resistance among the isolates; the separation between the susceptible and resistant population was absent or less clear for P. multocida and A. pleuropneumoniae. Resistance to tiamulin amounted to 2.0% in A. pleuropneumoniae; the only species where a breakpoint for tiamulin has been set. Trimethoprim/sulfamethoxazole exhibited very wide, multimodal MIC distributions. Several isolates of P. multocida and S. suis had distinctly higher MICs to spectinomycin (>512 μg mL−1), indicating acquired resistance to this compound. Among the five porcine pathogens, MICs of B. bronchiseptica were the highest and those of G. parasuis the lowest, but for individual antibiotics there were several exceptions. For B. bronchiseptica interpretive criteria are available for four antimicrobial agents allowing some data interpretation. Susceptibility results are extremely variable (Supplementary Table S10). All B. bronchiseptica isolates were resistant to amoxicillin, and 51.1% were resistant to florfenicol whereas 48.9% were florfenicol-intermediate susceptible. For both compounds none of the isolates was susceptible. In contrast, the isolates were merely susceptible to the macrolide antibiotics tildipirosin and tulathromycin. The lack of defined CLSI breakpoints for G. parasuis hampered a comparison of the percentages of resistance to the other porcine pathogens.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Cattle isolates In cattle, a total of 307 isolates were recovered from BRD cases: 145 P. multocida, 133 M. haemolytica and 29 H. somni (Supplementary Tables S4–S6). The large majority of these were susceptible to antibiotics for which a CLSI veterinary breakpoint is available. Resistance to ceftiofur was absent in all three organisms. For amoxicillin and cefquinome, no CLSI breakpoints are available. Amoxicillin shows a bimodal MIC distribution for M. haemolytica, suggesting the development of resistance in some isolates, whereas one P. multocida isolate had a distinctly higher MIC value. In contrast, MIC distribution for amoxicillin/clavulanic acid was monomodal, as applies to cefquinome and ceftiofur. The bovine isolates ranged in their colistin MICs between ≤0.06 and 16 μg mL−1 with MIC50 and MIC90 values of 0.25 and 0.25–2 μg mL−1, respectively. The MIC distributions for marbofloxacin were similar to that of enrofloxacin and danofloxacin, for which clinical resistance was low (0.8–2.8%). Similarly, resistance to florfenicol was low (2.1–2.3%) for the isolates from both species. The highest resistance percentage was observed for tetracycline at 29.7% for P. multocida and 19.6% for M. haemolytica, whereas resistance of H. somni was 3.5%. All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%. MIC values for the older macrolide tilmicosin were similar, whereas MICs for tylosin were markedly higher for P. multocida and M. haemolytica. For both species, MIC90 values were 16–128 μg mL−1 for tiamulin and lincomycin, while both compounds showed markedly lower MIC90 values for H. somni (0.5 and ≤4 μg mL−1, respectively). Lincomycin/spectinomycin and trimethoprim/sulfamethoxazole exhibited broad multimodal MIC patterns. While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
91 more claims
Create a free account to see all 152 claims and every source verdict.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 27
- The quote only partly states this claim. 2
Citations
Cites
Defining and combating antibiotic resistance from One Health and Global Health perspectives
Hernando-Amado, S., Coque, T. M., Baquero, F., & Martínez, J. L. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0503-9 · Cited by 1,224
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30141-9 · Cited by 942 · cited 1×
“Although AMR-associated foodborne and zoo-notic bacterial pathogens are known to transfer between animals and humans, it remains unclear whether the use of antimicrobials in farm animals directly drives AMR in humans (Tang et al., 2017; Martak et al., 2022).”
Ma, F., Xu, S., Tang, Z., Li, Z., & Zhang, L. (2021) · Biosafety and Health · doi:10.1016/j.bsheal.2020.09.004 · Cited by 377 · cited 1×
“The One Health approach emphasizes the standardization of surveillance methods for AMR across nations, and encourages countries to implement domestic action plans to monitor and to assess AMR patterns of clinical isolates (Boqvist et al., 2018; Ma et al., 2021; World Health Organization, 2025).”
Sweeney, M. T., Lubbers, B. V., Schwarz, S., & Watts, J. L. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky043 · Cited by 324
(2019) · Wiley eBooks · doi:10.1002/9781119350927 · Cited by 302
Assessing the antimicrobial susceptibility of bacteria obtained from animals
Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A. P., & Gaastra, W. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.12.013 · Cited by 236 · cited 3×
“It is, therefore, important to present the MIC frequency distributions (Supplementary Tables S4–S11) to allow retrospective data interpretation (Schwarz et al., 2010).”
Self-citationSegura, M., Aragon, V., Brockmeier, S., Gebhart, C., Greeff, A., Kerdsin, A., O’Dea, M., Okura, M., Saléry, M., Schultsz, C., et al. (2020) · Pathogens · doi:10.3390/pathogens9050374 · Cited by 187 · cited 1×
“…major respiratory tract pathogen responsible for pneumonia in pigs, can also cause a variety of other diseases including meningitis, arthritis, peri-and endocarditis, polyserositis, septicemia, abortion and sudden death (Segura et al., 2020; Dechêne-Tempier et al., 2021; Vilaró et al., 2025).”
Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis
Weinert, L. A., Chaudhuri, R. R., Wang, J., Peters, S. E., Corander, J., Jombart, T., Baig, A., Howell, K. J., Vehkala, M., Välimäki, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7740 · Cited by 170 · cited 1×
“Some pathogenic S. suis strains have zoonotic potential, causing meningitis in humans (Weinert et al., 2015).”
(EFSA), E. F. S. A., & European Medicines Agency (EMA) (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8589 · Cited by 151
Garch, F. E., de Jong, A., Simjee, S., Moyaert, H., Klein, U., Ludwig, C., Marion, H., Haag‐Diergarten, S., Richard‐Mazet, A., Thomas, V. M., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.04.009 · Cited by 146
Self-citation
Research works printed but not linked: 9
- 2018, Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals. CLSI standard VET01
- 2024, Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals. CLSI supplement VET01S
- 2024, Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents
- 2024, Veterinary antibiotic resistance and sales surveillance report (UK-VARSS, 2023)
- Woolums, 2015, Ruminant respiratory system, 583
- 2015, Global action plan on antimicrobial resistance
- 2024, WHO list of medically important antimicrobials, 7th revision
- 2025, Global antibiotic resistance surveillance report 2025: WHO global antimicrobial resistance and use surveillance system (glass)
- 2021, Terrestrial animal health code, 8
Cited by
Actinobacillus pleuropneumoniae – today's perspective on advances and challenges (2017- 2026)
Hennig‐Pauka, I., Strutzberg‐Minder, K., & Langford, P. R. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05791-3
“Most practitioners consider antibiotic resistance as a concern rather than a major practical issue, as at least in Europe, APP is susceptible to antimicrobials in general use when tested under in vitro conditions [81, 86, 96, 112, 113].”
InfluentialZhen, Z., Baihe, M., Guo, M., Yuxuan, W., & Lianrui, L. (2026) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2026.102519
Tan, M., Liu, C.-L., Zhou, Q., Yang, Q., Gao, T., Wan, M., Jiang, H., & Ji, H.-Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10733930/v1
Metadata
- Authors
- de Jong, A., Temmerman, R., Rose, M., Simjee, S., El Garch, F., & on behalf of the VetPath Study Group
- Affiliations
- VetPath Study Group, CEESA
- ORCID
- Temmerman, Robin
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2026-02-23
- Volume
- 17
- Pages
- 1745115-1745115
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC12967990
- OpenAlex
- W7131063878
- Cited by
- 3
- References
- 64
- Citations by year
- 2026: 3
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Zoetis
- Kela
- Huvepharma
- Elanco Animal Health
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, Pasteurella multocida, Mannheimia haemolytica, Histophilus somni, Actinobacillus pleuropneumoniae, Haemophilus parasuis, Bordetella bronchiseptica, Streptococcus suis, tetracycline resistance, macrolide resistance, multidrug resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens. https://app.cochat.ai/papers/10.3389/fmicb.2026.1745115
- The paper
- de Jong, A., Temmerman, R., Rose, M., Simjee, S., El Garch, F., & on behalf of the VetPath Study Group. (2026). Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2026.1745115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.